GET THE APP

From Plants to Patients Bioactive Compounds as Therapeutic Agents
..

Molecular and Genetic Medicine

ISSN: 1747-0862

Open Access

Commentary - (2024) Volume 18, Issue 5

From Plants to Patients Bioactive Compounds as Therapeutic Agents

Russell Dean*
*Correspondence: Russell Dean, Department of Medical Laboratory Sciences, Zhejiang University, Hangzhou 310058, China, Email:
Department of Medical Laboratory Sciences, Zhejiang University, Hangzhou 310058, China

Received: 13-Aug-2024, Manuscript No. jmgm-24-152002; Editor assigned: 15-Aug-2024, Pre QC No. P-152002; Reviewed: 27-Aug-2024, QC No. Q-152002; Revised: 02-Sep-2024, Manuscript No. R-152002; Published: 09-Sep-2024 , DOI: 10.37421/1747-0862.2024.18.685
Citation: Dean, Russell. “From Plants to Patients Bioactive Compounds as Therapeutic Agents.” J Mol Genet Med 18 (2024): 685.
Copyright: © 2024 Dean R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Introduction

The exploration of bioactive compounds derived from plants has gained significant attention in recent decades due to their potential therapeutic applications. These compounds, which include alkaloids, flavonoids, terpenoids and phenolic acids, exhibit a range of biological activities that can benefit human health. This review discusses the pathways from plant-derived bioactive compounds to clinical applications, examining their mechanisms of action, therapeutic benefits, challenges in development and future directions in research. The utilization of plants for medicinal purposes dates back thousands of years, with various cultures employing herbal remedies for healing. As modern science advances, there is renewed interest in the bioactive compounds found in plants and their potential roles as therapeutic agents. Bioactive compounds are natural substances that can exert beneficial effects on living organisms. This review focuses on the transition from plant sources to clinical applications, highlighting key bioactive compounds, their therapeutic properties and the obstacles faced in their development.

Bioactive compounds can be categorized into several classes based on their chemical structures and biological activities Alkaloids Nitrogencontaining compounds that often have potent pharmacological effects. Examples include morphine and caffeine. Flavonoids a diverse group of polyphenolic compounds known for their antioxidant properties. Quercetin and kaempferol are well-known examples. Terpenoids also known as isoprenoids, these compounds are involved in the aroma and flavor of plants and possess anti-inflammatory and antimicrobial properties. Limonene and menthol are common terpenoids. Phenolic Acids These compounds are recognized for their antioxidant activities and include ferulic acid and caffeic acid [1].

Description

Antioxidant Activity Many bioactive compounds can neutralize free radicals, reducing oxidative stress and preventing cellular damage. Antiinflammatory Effects Compounds such as curcumin and resveratrol have been shown to inhibit inflammatory pathways, providing therapeutic benefits in chronic inflammatory diseases. Antimicrobial Properties Several plant-derived compounds demonstrate antimicrobial activity against bacteria, fungi and viruses. Cell Signaling Modulation Bioactive compounds can influence cellular signaling pathways, affecting processes like apoptosis, cell proliferation and immune response. Bioactive compounds like flavonoids have been associated with cardiovascular health benefits. Studies have shown that consumption of flavonoid-rich foods is linked to reduced blood pressure, improved endothelial function and decreased LDL cholesterol levels. Mechanistically, flavonoids enhance nitric oxide production and reduce inflammation, contributing to vascular health. Many bioactive compounds exhibit low bioavailability, meaning that only a small fraction reaches systemic circulation in an active form. Factors such as solubility, stability and the presence of food can influence bioavailability.

Strategies to enhance bioavailability include formulation modifications and the use of nanoparticles. Variability in plant sources can lead to inconsistencies in bioactive compound content. Ensuring standardization and quality control in herbal products is crucial for clinical efficacy [2]. Regulatory frameworks need to be established to ensure the safety and efficacy of plantderived therapeutics. While numerous preclinical studies support the health benefits of bioactive compounds, there is a lack of large-scale clinical trials. Rigorous clinical research is necessary to establish definitive therapeutic claims and dosing regimens. Navigating the regulatory landscape for plant-derived therapeutics can be complex. The classification of bioactive compounds as dietary supplements, pharmaceuticals, or food additives varies by region, impacting their marketability and accessibility. Many cultures have long relied on traditional medicine, utilizing local plants for health benefits. Recognizing the value of traditional knowledge and integrating it with modern scientific research can lead to the discovery of new bioactive compounds. Collaboration between traditional healers and researchers can pave the way for evidence-based practices that honor both cultural heritage and scientific rigor [3].

The anticancer properties of various bioactive compounds have been extensively researched. Compounds such as curcumin, found in turmeric and resveratrol, found in grapes, have shown promise in inhibiting tumor growth and inducing apoptosis in cancer cells. These compounds can interfere with multiple signaling pathways involved in cancer progression, highlighting their potential as adjuncts to conventional cancer therapies. Bioactive compounds such as ginkgo biloba extract and omega-3 fatty acids (derived from flaxseed and fish) have demonstrated neuro protective effects. These compounds can reduce oxidative stress and inflammation in neural tissues, potentially lowering the risk of neurodegenerative diseases like Alzheimer’s and Parkinson’s. The role of bioactive compounds in managing metabolic disorders, particularly type 2 diabetes and obesity, is gaining interest. For instance, berberine, derived from plants like goldenseal, has been shown to improve insulin sensitivity and lower blood glucose levels. Additionally, polyphenols from green tea have been associated with weight management and fat oxidation.

Combining bioactive compounds with conventional therapies may enhance treatment outcomes. Integrative approaches that include lifestyle modifications, dietary changes and supplementation could provide a holistic strategy for managing chronic diseases. Biotechnology offers innovative methods for the production and extraction of bioactive compounds. Techniques such as synthetic biology and metabolic engineering can facilitate the development of bioactive compounds with enhanced properties. The future of bioactive compounds in therapy may lie in personalized medicine. Individual variations in genetics, metabolism and lifestyle can influence the efficacy of bioactive compounds, necessitating tailored therapeutic approaches. Continued research is essential to explore new plant sources and bioactive compounds. Investigating traditional medicinal plants and ethnobotanical knowledge can unveil novel therapeutic agents that have yet to be studied [4,5].

Conclusion

The therapeutic applications of bioactive compounds derived from plants have significant implications for public health. As the global population ages and the prevalence of chronic diseases increases, the demand for effective, safe and affordable treatments grows. Plant-based bioactive compounds can provide alternative or complementary options to conventional pharmaceuticals, particularly in preventive healthcare. Incorporating bioactive compounds into daily diets can serve as a preventive measure against various diseases. Public health initiatives that promote the consumption of fruits, vegetables and herbal products rich in bioactive compounds can help reduce the burden of diseases such as cardiovascular issues, diabetes and cancer. Education on the health benefits of these compounds can encourage healthier dietary patterns and lifestyle choices. Bioactive compounds derived from plants represent a valuable resource in the development of therapeutic agents. Their diverse biological activities offer significant potential for the prevention and treatment of various health conditions. However, challenges related to bioavailability, standardization and regulatory hurdles must be addressed to facilitate their translation into clinical practice. As research progresses, the integration of bioactive compounds into healthcare could play a pivotal role in enhancing human health and well-being.

Acknowledgment

None.

Conflict of Interest

None.

References

  1. Cimmino, Alessio, Marco Masi, Marco Evidente and Stefano Superchi, et al. “Application of mosher’s method for absolute configuration assignment to bioactive plants and fungi metabolites.” J Pharm Biomed Anal 144 (2017): 59-89.
  2. Google Scholar, Crossref, Indexed at

  3. Le, DucDat, Sanghee Han, Jeongjun Ahn and Jayeon Yu, et al. “Analysis of antioxidant phytochemicals and anti-Inflammatory effect from Vitex rotundifolia Lf.” Antioxidants 11 (2022): 454.
  4. Google Scholar, Crossref, Indexed at

  5. Le, Duc Dat, Kyung Hyun Min and Mina Lee. “Antioxidant and anti-Inflammatory capacities of fractions and constituents from Vicia tetrasperma.Antioxidants 12 (2023): 1044.
  6. Google Scholar, Crossref, Indexed at

  7. Mullen, W., B. Nemzer, A. Stalmach and S. Ali, et al. “Polyphenolic and hydroxycinnamate contents of whole coffee fruits from China, India and Mexico.” J Agric Food Chem 61 (2013): 5298-5309.
  8. Google Scholar, Crossref, Indexed at

  9. Tatefuji, Tomoki, Noboru Izumi, Tsunetaka Ohta and Shigeyuki Arai, et al. “Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility.Biol Pharm Bull 19 (1996): 966-970.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 3919

Molecular and Genetic Medicine received 3919 citations as per Google Scholar report

Molecular and Genetic Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward